Related references
Note: Only part of the references are listed.Docosahexaenoic Acid-Rich Fish Oil Supplementation Reduces Kinase Associated with Insulin Resistance in Overweight and Obese Midlife Adults
Rohith N. Thota et al.
NUTRIENTS (2020)
Effects of fish oil supplementation on glucose control and lipid levels among patients with type 2 diabetes mellitus: a Meta-analysis of randomized controlled trials
Chao Gao et al.
LIPIDS IN HEALTH AND DISEASE (2020)
DHA-enriched fish oil reduces insulin resistance in overweight and obese adults
K. A. Abbott et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2020)
Omega-3 Eicosapentaenoic Acid (EPA) Rich Extract from the MicroalgaNannochloropsisDecreases Cholesterol in Healthy Individuals: A Double-Blind, Randomized, Placebo-Controlled, Three-Month Supplementation Study
Amanda Rao et al.
NUTRIENTS (2020)
Effects of EPA and DHA on blood pressure and inflammatory factors: a meta-analysis of randomized controlled trials
Xiao-fei Guo et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2019)
Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD
Marja-Riitta Taskinen et al.
CURRENT ATHEROSCLEROSIS REPORTS (2019)
Polyunsaturated Fatty Acids and Glycemic Control in Type 2 Diabetes
Vibeke H. Telle-Hansen et al.
NUTRIENTS (2019)
Dietary Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA) Operate by Different Mechanisms to Modulate Hepatic Steatosis and Hyperinsulemia in fa/fa Zucker Rats
Lena Hong et al.
NUTRIENTS (2019)
Effects of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on Atherogenic Lipid/Lipoprotein, Apolipoprotein, and Inflammatory Parameters in Patients With Elevated High-Sensitivity C-Reactive Protein (from the ANCHOR Study)
Michael Miller et al.
AMERICAN JOURNAL OF CARDIOLOGY (2019)
Metabolic Syndrome-Role of Dietary Fat Type and Quantity
Peter Clifton
NUTRIENTS (2019)
The Global Epidemic of the Metabolic Syndrome
Mohammad G. Saklayen
CURRENT HYPERTENSION REPORTS (2018)
Risk factors and metabolic abnormality of patients with non-alcoholic fatty liver disease: Either non-obese or obese Chinese population
Shou-Wu Lee et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2018)
The Differential Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Cardiometabolic Risk Factors: A Systematic Review
Jacqueline K. Innes et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Lipid Effects of Icosapent Ethyl in Women with Diabetes Mellitus and Persistent High Triglycerides on Statin Treatment: ANCHOR Trial Subanalysis
Eliot A. Brinton et al.
JOURNAL OF WOMENS HEALTH (2018)
Fish oil and fenofibrate inhibit pancreatic islet hypertrophy, and improve glucose and lipid metabolic dysfuntions with different ways in diabetic KK mice
Maki Nakasatomi et al.
OBESITY RESEARCH & CLINICAL PRACTICE (2018)
Efficacy of omega-3 polyunsaturated fatty acids supplementation in managing overweight and obesity: A meta-analysis of randomized clinical trials
Y. Y. Zhang et al.
JOURNAL OF NUTRITION HEALTH & AGING (2017)
Metabolic Syndrome: Clinical and Policy Implications of the New Silent Killer
Dawn Harris Sherling et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2017)
Fish oil supplementation and insulin sensitivity: a systematic review and meta-analysis
Huanqing Gao et al.
LIPIDS IN HEALTH AND DISEASE (2017)
The Ratio of Eicosapentaenoic Acid (EPA) to Arachidonic Acid may be a Residual Risk Marker in Stable Coronary Artery Disease Patients Receiving Treatment with Statin Following EPA Therapy
Shigemasa Tani et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2017)
AKT/PKB Signaling: Navigating the Network
Brendan D. Manning et al.
CELL (2017)
Eicosapentaenoic acid inhibits intestinal β-carotene absorption by downregulation of lipid transporter expression via PPAR-α dependent mechanism
Puma Chandra Mashurabad et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2016)
Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial
Takahiro Sawada et al.
CARDIOVASCULAR DIABETOLOGY (2016)
The influence of eicosapentaenoic acid and docosahexaenoic acid on expression of genes connected with metabolism and secretory functions of ageing 3T3-L1 adipocytes
Adam Prostek et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2016)
Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice
Noriko Suzuki-Kemuriyama et al.
PLOS ONE (2016)
Effects of oral eicosapentaenoic acid versus docosahexaenoic acid on human peripheral blood mononuclear cell gene expression
Fumiyoshi Tsunoda et al.
ATHEROSCLEROSIS (2015)
Effect of DHA on plasma fatty acid availability and oxidative stress during training season and football exercise
Miquel Martorell et al.
FOOD & FUNCTION (2014)
Omega-3 fatty acids: new insights into the pharmacology and biology of docosahexaenoic acid, docosapentaenoic acid, and eicosapentaenoic acid
Michael H. Davidson
CURRENT OPINION IN LIPIDOLOGY (2013)
Eicosapentaenoic acid-enriched phospholipid ameliorates insulin resistance and lipid metabolism in diet-induced-obese mice
Xiaofang Liu et al.
LIPIDS IN HEALTH AND DISEASE (2013)
Eicosapentaenoic acid improves insulin sensitivity and blood sugar in overweight type 2 diabetic mellitus patients: a double-blind randomised clinical trial
Shokouh Sarbolouki et al.
SINGAPORE MEDICAL JOURNAL (2013)
Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies
J. Savovic et al.
HEALTH TECHNOLOGY ASSESSMENT (2012)
Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other Lipids: A review
Terry A. Jacobson et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2012)
Marine N-3 Polyunsaturated Fatty Acids Are Inversely Associated with Risk of Type 2 Diabetes in Asians: A Systematic Review and Meta-Analysis
Ju-Sheng Zheng et al.
PLOS ONE (2012)
Biological Effects of Add-On Eicosapentaenoic Acid Supplementation in Diabetes Mellitus and Co-Morbid Depression: A Randomized Controlled Trial
Roel J. T. Mocking et al.
PLOS ONE (2012)
Effects of Eicosapentaenoic Acid Versus Docosahexaenoic Acid on Serum Lipids: A Systematic Review and Meta-Analysis
Melissa Y. Wei et al.
CURRENT ATHEROSCLEROSIS REPORTS (2011)
The differential effects of EPA and DHA on cardiovascular risk factors
S. C. Cottin et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2011)
Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors
M. John Chapman et al.
EUROPEAN HEART JOURNAL (2010)
Effects of Fish Oil Supplementation on Markers of the Metabolic Syndrome
Maiken Hojgaard Pedersen et al.
JOURNAL OF PEDIATRICS (2010)
Omega-3 fatty acid supplements improve the cardiovascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity
Mahmoud Ebrahimi et al.
ACTA CARDIOLOGICA (2009)
Highly purified eicosapentaenoic acid reduces cardio-ankle vascular index in association with decreased serum amyloid A-LDL in metabolic syndrome
Noriko Satoh et al.
HYPERTENSION RESEARCH (2009)
Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men
Darshan S. Kelley et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2007)
Eicosapentaenoic acid reduces the progression of carotid intima-media thickness in patients with type 2 diabetes
Tomoya Mita et al.
ATHEROSCLEROSIS (2007)
Purified eicosapentaenoic acid reduces small dense LDL, remnant lipoprotein particles, and C-reactive protein in metabolic syndrome
Noriko Satoh et al.
DIABETES CARE (2007)
Influence of an algal triacylglycerol containing docosahexaenoic acid (22: 6n-3) and docosapentaenoic acid (22: 5n-6) on cardiovascular risk factors in healthy men and women
TAB Sanders et al.
BRITISH JOURNAL OF NUTRITION (2006)
PPAR-alpha and insulin sensitivity
M. M. Haluzik et al.
PHYSIOLOGICAL RESEARCH (2006)
Do eicosapentaenoic acid supplements attenuate age-related increases in arterial stiffness in patients with dyslipidemia? A preliminary study
H Tomiyama et al.
HYPERTENSION RESEARCH (2005)
Lipid responses to a dietary docosahexaenoic acid supplement in men and women with below average levels of high density lipoprotein cholesterol
KC Maki et al.
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2005)
Circulating triacylglycerol and apoE levels in response to EPA and docosahexaenoic acid supplementation in adult human subjects
R Buckley et al.
BRITISH JOURNAL OF NUTRITION (2004)
Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance
Y Park et al.
JOURNAL OF LIPID RESEARCH (2003)
Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension
RJ Woodman et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2002)
The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans
P Nestel et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2002)
Share Paper
